Morning and evening administration of pantoprazole: A study to compare the effect on 24-hour intragastric pH

被引:0
作者
Mussig, S
Witzel, L
Luhmann, R
Schneider, A
机构
关键词
acid-related diseases; intragastric pH; pantoprazole;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: To determine whether the time of administration (morning vs. evening) oi pantoprazole influences the effect of a 40 mg dose upon intragastric pH in healthy subjects. Design: Randomized, double-blind, two-period crossover study to compare intragastric pH following treatment with pantoprazole, 40 mg once daily for 7 days, the drug being given as either a morning or an evening dose before meals. Methods: Intragastric pH was measured for 24 h on three occasions. The baseline recording was made 2 days prior to the first treatment period and subsequent measurements were made on days 6 to 7 of each period. Adverse events were recorded and fasting laboratory variables measured. Results: Twelve subjects were evaluable for efficacy. Increases in median pH over 24 h were observed in all subjects with both dosage regimens. There was a greater increase from baseline in 24-h median pH values following morning than evening administration of pantoprazole (P<0.05). This difference was due to a greater effect on median daytime pH (07.00-19.00 h, P<0.01) compared with that after evening administration. No adverse events were reported and there were no clinically significant changes in laboratory variables. Conclusion: The study supports the recommendation of a once-daily morning dosage regimen of pantoprazole 40 mg in the treatment of acid-related diseases.
引用
收藏
页码:599 / 602
页数:4
相关论文
共 14 条
  • [1] CHIVERTON SG, 1992, ALIMENT PHARM THERAP, V6, P103
  • [2] HARTMANN M, 1992, HELLENIC J GASTROE S, V5, P112
  • [3] JUDMAIER G, 1994, ALIMENT PHARM THERAP, V8, P81
  • [4] COMPARATIVE TRIAL OF PANTOPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX ESOPHAGITIS - RESULTS OF A GERMAN MULTICENTER STUDY
    KOOP, H
    SCHEPP, W
    DAMMANN, HG
    SCHNEIDER, A
    LUHMANN, R
    CLASSEN, M
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 20 (03) : 192 - 195
  • [5] LONDONG W, 1994, ALIMENT PHARM THE S1, V9, P39
  • [6] OMEPRAZOLE - AN UPDATED REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN ACID-RELATED DISORDERS
    MCTAVISH, D
    BUCKLEY, MMT
    HEEL, RC
    [J]. DRUGS, 1991, 42 (01) : 138 - 170
  • [7] MOSSNER J, 1995, ALIMENT PHARM THERAP, V9, P321
  • [8] MULLER P, 1992, Z GASTROENTEROL, V30, P771
  • [9] PRICHARD PJ, 1985, GASTROENTEROLOGY, V88, P64, DOI 10.1016/S0016-5085(85)80133-5
  • [10] REILL L, 1993, GASTROENTEROLOGY, V104, pA177